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Genomic imprinting is an epigenetic phenomenon restricting gene expression in a manner dependent
on parent of origin. Imprinted gene products are critical regulators of growth and development, and
imprinting disorders are associated with both genetic and epigenetic mutations, including disruption of
DNA methylation within the imprinting control regions (ICRs) of these genes. It was recently reported that
some patients with imprinting disorders have a more generalised imprinting defect, with hypomethylation
at a range of maternally methylated ICRs. We report a cohort of 149 patients with a clinical diagnosis of
Beckwith–Wiedemann syndrome (BWS), including 81 with maternal hypomethylation of the KCNQ1OT1
ICR. Methylation analysis of 11 ICRs in these patients showed that hypomethylation affecting multiple
imprinted loci was restricted to 17 patients with hypomethylation of the KCNQ1OT1 ICR, and involved
only maternally methylated loci. Both partial and complete hypomethylation was demonstrated in
these cases, suggesting a possible postzygotic origin of a mosaic imprinting error. Some ICRs, including
the PLAGL1 and GNAS/NESPAS ICRs implicated in the aetiology of transient neonatal diabetes and
pseudohypoparathyroidism type 1b, respectively, were more frequently affected than others. Although
we did not find any evidence for mutation of the candidate gene DNMT3L, these results support the
hypotheses that trans-acting factors affect the somatic maintenance of imprinting at multiple maternally
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methylated loci and that the clinical presentation of these complex cases may reflect the loci and tissues
affected with the epigenetic abnormalities.
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Introduction
The expression of imprinted genes in the mammalian
genome is dependent on parental origin. These genes
have key roles in the control of foetal growth and many of
them have been implicated in human growth disorders
and cancer.1 – 3 Epigenetic modifications including DNA
methylation differentially mark imprinted genes in egg
and sperm and lead to the unequal expression of parental
alleles in somatic cells.1 Maintenance of differential DNA
methylation between maternal and paternal alleles of
specific sequences is crucial to proper imprinting control,
and methylation defects at imprinted loci have been
described in human imprinting disorders.4
Beckwith–Wiedemann syndrome (BWS, OMIM 13650) is
a tumour-associated overgrowth disorder that is mainly
caused by the dysregulation of a cluster of imprinted genes
located at chromosome 11p15.5.5 Although some familial
cases with dominant maternal inheritance have been
described,6,7 BWS cases are mostly sporadic and are char-
acterised by methylation abnormalities at one of the two
imprinting control regions (ICRs) (H19 and KCNQ1OT1 ICR,
also known as IC1 and IC2) or paternal uniparental disomy
(UPD) at 11p15.5. Several genes with growth-regulatory
properties are part of the 11p15.5 cluster, including IGF2 and
H19, which are controlled by the H19 ICR, and CDKN1C and
KCNQ1OT1, which are controlled by the KCNQ1OT1 ICR.
We recently demonstrated that gain of methylation at the
H19 ICR (IC1 defect, ICD1) is independent of the DNA
sequence context in several BWS patients and proposed that
these molecular defects generally arise as de novo epimuta-
tions in early embryogenesis.8
A subset of BWS patients with hypomethylation at the
KCNQ1OT1 ICR (IC2 defect, ICD2) have loss of methyl-
ation at other imprinted loci.9 Hypomethylation of multi-
ple maternally methylated ICRs including KCNQ1OT1 has
also been demonstrated in cases of transient neonatal
diabetes10,11 (TND, OMIM 601410). TND is a disease
characterised by intrauterine growth retardation and
transient hyperglycaemia that results from dysregulation
of the imprinted growth inhibitor and antiapoptotic
PLAGL1 (ZAC) gene located at chromosome 6q24.12 A
minority of TND patients have BWS features, such as
macroglossia and abdominal wall defects, suggesting an
interaction between the 6q24 and 11p15.5 loci. However,
no molecular defect at PLAGL1 has been reported in BWS
patients so far and the relationship between BWS and TND
remains undefined.9,13
We have further investigated the role of the imprinted
genes other than the 11p15.5 cluster in BWS, by analysing
DNA methylation at 11 ICRs with multiple techniques and
screening a large number of cases through a multicentre
study. The results obtained demonstrate that a subset of
BWS patients display hypomethylation at multiple mater-
nally methylated ICRs, including those involved in TND
and pseudohypoparathyroidism type 1b (PHP1b), and
support the hypothesis that multiple maternal hypomethy-
lation may present with different clinical phenotypes.
Patients and methods
Patients
The patients comprised 149 individuals with clinical
diagnosis of BWS according to the criteria reported by
DeBaun et al.14 These included 105 patients from Italy and
44 from the Netherlands (Table 1). Their clinical features
are summarised in Table 2. Genetic analyses of the Italian
cohort were performed with the informed consent of the
Table 1 Classification of epigenetic defects found in 149 BWS patients
Italian cohort Dutch cohort Total
No. of
patients
No. of patients with
multiple defects
No. of
patients
No. of patients with
multiple defects
No. of
patients
No. of patients with
multiple defects Fraction
No defect found 24 0 6 0 30 0 0
UPD11 13 0 5 0 18 0 0
ICD1a 16 0 4 0 20 0 0
ICD2 52 9 29 8 81 17 0.21
Total 105 9 44 8 149 17
BWS, Beckwith–Wiedemann syndrome.
aFour of these individuals carried a maternally inherited microdeletion in the H19 ICR (Sparago et al6).
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Table 2 Clinical features of the BWS patients with multiple maternal hypomethylation
Patients Sex
Additional
genes
involved
Birthweight
centilea
Postnatal
overgrowthb
Macro-
glossia
Abdominal
wall defect
Pits and
creases
Hypo-
glycaemia
Poly-
hydramnio’s
Naevus
flammeus
Hemihyper-
trophy
Organo-
megaly
Childhood
cancer
Born after
IVF Others
BWS1 M MEST,
PLAGL1,
IGF2R, PEG3
10 – 25 Y Y Y N N N Y N N N N Twinc,
respiratory
distress
BWS2 M MEST,
PLAGL1,
IGF2R
10 – 50 Y Y Y Y Y N Y Y Y N N Cryptorchidism,
hypothyroidism
BWS3 F MEST 10 – 50 Y N Y Y N N N N Y N N Speech
retardation,
seizures
BWS4 M MEST,
PLAGL1,
GNAS,
NESPAS
90 Y Y N N N N Y N N N N
BWS5 F GNAS,
IGF2R
75 NA Y Y Y Y N N N Y N N
BWS6 NA PLAGL1,
IGF2R,
GNAS
NA NA NA Y NA NA NA NA NA NA NA Fetus
BWS7 M PLAGL1 75 Y Y Y N N N N N N N Y Cryptorchidism,
hypospadias
BWS8 M IGF2R,
GNAS,
NESPAS
497 Y Y N N N N N N N N N
BWS9 F PLAGL1 90 Y Y N Y Y N N N Y N N ASD
BWS10 F PLAGL1,
NESPAS,
GRB10
10 NA Y Y N N N N N N N N
BWS11 M MEST 97 N Y Y Y Y Y Y Y Y N N Apnoea, feeding
and hearing
problems
BWS12 F GRB10 50 N Y Y N N NA NA N N N N Premature birth
(28 weeks),
cryptorchidism
BWS13 F MEST,
GNAS,
NESPAS
50 Y Y N N N N Y N Y N N
BWS14 F GNAS,
NESPAS
10 Y Y Y Y N Y N N N N N
BWS15 F GNAS,
NESPAS
50 – 90 NA Y Y N Y Y N N N N N Macrostomia
BWS16 F GNAS,
NESPAS
97 NA Y Y Y Y Y Y N Y N N Premature birth
(28 weeks)
BWS17 F NESPAS 90 N Y N N Y N Y N N N N
Multiple
LOM
58 (±35) 9/17 (0.53) 15/16 (0.94) 12/17 (0.71) 7/16 (0.44) 7/16 (0.44) 4/15 (0.27) 7/15 (0.47) 2/16 (0.12) 7/16 (0.44) 0/16 (0.00) 1/17 (0.06)
KCNQ1OT1
LOM
80 (±21) 18/36 (0.50) 42/47 (0.89) 36/46 (0.78) 31/44 (0.70) 19/42 (0.45) 7/46 (0.15) 33/46 (0.72) 19/46 (0.41) 12/45 (0.27) 1/46 (0.02) 4/46 (0.09)
P-valued 0.06 0.60 0.53 0.06 0.92 0.32 0.08 0.04 0.20 0.55 0.71
ASD, atrial septal defect; BWS, Beckwith–Wiedemann syndrome; N, no; NA, not available; Y, yes.
aBirth weight centiles were corrected for gestational age and twin pregnancy.15,16
b490 centile.
cHormone treatment of the mother for infertility.
dw2 testing was used in all cases, but birthweight centile, for which t-testing analysis was used.
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parents of the patients. The experimental plan was approved
by the ethical committees of the Second University
of Naples, Italy. The collection of clinical data in the
Netherlands was approved by the ethical committee of the
Academic Medical Centre in Amsterdam (MEC 99/030), and
the experiments were performed in accordance with the
local (ethical) protocols for research on patient material.
DNA methylation analysis of the imprinted loci
The DNA methylation of ICRs at various imprinted loci was
analysed in DNA derived from peripheral blood leukocytes
using four different techniques. The H19 ICR and the
KCNQ1OT1 ICR were analysed by Southern blotting
hybridisation, as described earlier.17 The KCNQ1OT1 ICR
and all the other ICRs were analysed by combined
bisulphite restriction analysis (COBRA) and methylation-
specific PCR (MS-PCR). For the COBRA, 2 mg of genomic
DNA was treated with sodium bisulphite, PCR amplified,
the PCR product digested with a restriction enzyme
containing a CpG dinucleotide in its target sequence and
the fragments separated on a polyacrylamide gel. In some
individuals, the methylation of the KCNQ1OT1, MEST
(PEG1) and PLAGL1 ICRs was also analysed by bisulphite
sequencing. In this case, the PCR products were cloned in
Topo pCR2.1 vector (Invitrogen) and the clones sequenced.
Primer sequences, genomic locations and amplicon sizes
of relevant assays are detailed in Supplementary Table 1;
further experimental details are available on request.
MS-PCR was performed exactly as described.18
Methylation analysis of classical satellite DNA
DNA methylation of classical satellites 2 and 3 was
analysed by Southern blotting, as described.19 Two micro-
grams of DNA were digested overnight with HpaII, MspI
and McrBC, in separate tubes. Blots were hybridised with
oligonucleotide probes specific for satellite 2 of chromo-
somes 1 and 16 and satellite 3 of chromosome 9.
Mutation analysis of the DNMT3L gene
The DNMT3L gene was analysed by sequencing all exons
and their flanking intronic regions. The primers and PCR
conditions used are as described;20 DNA sequencing was
obtained from PRIMM (Italy).
Statistical analysis
Fisher’s exact testing and w2 analysis were used as appro-
priate. Statistical significance was taken at the 5% level.
Results
DNA methylation defects at multiple imprinted loci in
BWS
We investigated 149 individuals affected with BWS for
the presence of DNA methylation defects at imprinted loci
other than the 11p15.5 cluster. In all cases, leukocyte-
derived DNA was analysed. The BWS samples were
classified for the presence of hypermethylation at the
H19 ICR (ICD1), hypomethylation at the KCNQ1OT1 ICR
(ICD2), paternal UPD at 11p15.5 (UPD11) or no epigenetic
defect at 11p15.5, as described earlier5,21,22 (see Table 1 and
Supplementary Figure 1). The same samples were then
analysed for the presence of methylation defects at other
imprinted loci. One ICR normally methylated on the
paternal allele, GTL2-IG (14q32), and eight maternally
methylated ICRs, PLAGL1 (6q24), IGF2R (6q25.3), GRB10
(7p21), MEST (7q32.2), SNRPN (15q11), PEG3 (19q13),
GNAS (20q13.32) and NESPAS (20q13.32), were investi-
gated. At these loci, methylation levels were determined by
using both COBRA and MS-PCR (Table 3).
Abnormal methylation at loci other than 11p15.5
was detected in 17 patients with ICD2 (21%, see Table 1).
The results were reported as unme/me ratios and named
‘loss of methylation values’ (Table 3). In patients with
multiple methylation anomalies, only maternally methy-
lated ICRs were affected. No methylation defect of
imprinted loci other than 11p15 was detected in patients
with ICD1, or in those with UPD11, or in those with no
detected anomaly of chromosome 11p15.5. No methyla-
tion changes were observed in 120 normal controls with
MS-PCR and 100 normal controls with COBRA. The
number and type of loci involved and the extent of
hypomethylation varied from patient to patient (Table 3).
Apart from KCNQ1OT1, methylation defects were found at
MEST in six to seven cases, PLAGL1 in seven cases, IGF2R in
six cases, GNAS in eight cases, NESPAS in 10 cases and
GRB10 in four cases. The observed hypomethylation
defects were strikingly mosaic in form; individual patients
showed epimutations ranging from modest to total
hypomethylation at different loci. Generally, MS-PCR
appeared to be more sensitive to allelic imbalances.
Nevertheless, qualitatively, the results obtained with
the two different methods were comparable (Table 3 and
Figure 1a and b).
As MS-PCR and COBRA assay the methylation of only a
few CpGs at each site, we investigated the extent of the
methylation losses, by bisulphite-sequencing analysis of
two cases from the Italian cohort showing significant
hypomethylation of the MEST and PLAGL1 ICRs (Figure 2).
The patient DNA showed essentially complete hypo-
methylation within the amplicons sequenced. Demonstra-
tion of heterozygosity by the analysis of closely linked
SNPs and microsatellites excluded the deletion of the
methylated allele in the cases with complete absence of
methylation at the ICR (data not shown).
The specificity of the methylation defects was investi-
gated by the analysis of repetitive sequences. We analysed
the methylation of satellites 2 and 3, by Southern blotting,
in four patients with multiple hypomethylation. The
results showed that methylation was present at essentially
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control levels in all individuals investigated (Supplementary
Figure 2).
Overall, these results demonstrate that a subset of BWS
patients display a complex but specific hypomethylation
defect involving multiple maternally methylated
imprinted loci. Interestingly, the hypomethylated loci
included the PLAGL1 locus implicated in TND, and the
GNAS and NESPAS loci implicated in PHP1b.
Clinical characteristics of patients with multiple
maternal hypomethylation
The clinical features of the patients with multiple hypo-
methylation were compared with those of the patients
with loss of methylation restricted to KCNQ1OT1 (Table 2).
The birth weight of the patients with multiple hypomethy-
lation was on average lower than that of the subgroup
with isolated KCNQ1OT1 hypomethylation (58th±35 vs
79th±21 centile). This difference is just over the limits
of statistical significance (P¼0.06). However, the low
frequency of neonatal macrosomia was particularly evident
among the cases with severe hypomethylation (38th±34,
see Table 3, in bold). Intriguingly, some of these individuals
showed postnatal overgrowth. The frequencies of nevus
flammeus and hemihypertrophy among the patients with
multiple defects were lower than those observed among
the patients with only KCNQ1OT1 hypomethylation
(P¼0.03 and P¼ 0.04, respectively). In addition, some
patients with multiple hypomethylation displayed charac-
teristics not usually associated with BWS, such as speech
retardation (BWS3), peri/postnatal apnoea, feeding diffi-
culties, hearing problems (BWS11) and premature birth (28
weeks of gestation, BWS12 and BWS16). Overall, these data
suggest that maternal hypomethylation in addition to that
at 11p15.5 may modify the clinical presentation of BWS.
Mutation analysis of DNMT3L
In the mouse, Dnmt3L is required for establishing maternal
imprints.23 We, therefore, looked for mutations at the
DNMT3L locus in the mothers of two patients (BWS1 and
BWS2) with severe hypomethylation at multiple imprint-
ing loci. We sequenced all exons and flanking intronic
regions. Only four single-nucleotide variations with respect
to the reference sequence (NT_011515) were detected, but
all of them corresponded to polymorphisms also found in
the normal population (db8129767, db2014457, db762424
and db2014264).
Discussion
Rossignol et al9 reported that a subgroup of BWS patients
displayed maternal methylation defects at imprinted loci
in addition to the KCNQ1OT1 ICR, raising the hypothesis
that genes other than those located at chromosome
11p15.5 were involved in the pathogenesis of BWS. In a
larger cohort of patients, we have demonstrated that theT
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epigenetic defects at loci other than 11p15.5 were limited
to loss of methylation at maternally methylated ICRs, and
that these abnormalities were restricted to the individuals
with loss of KCNQ1OT1 methylation. We also observed
that a specific set of ICRs were found more frequently
affected than others and that the patients with multiple
methylation defects often displayed atypical BWS pheno-
types.
The percentage of ICD2 patients with multiple hypo-
methylation was reported by Rossignol et al9 to be 25% in a
study of the KCNQ1OT1, IGF2R, MEST and SNRPN loci in
40 BWS cases. We have found a 20% frequency of multiple
KCNQ1OT1
PLAGL1
MEST
GNAS
NESPAS
IGF2R
GRB10
PEG3 PEG3
GRB10
IGF2R
GNAS
MEST
PLAGL1
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me
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me
unme
me
unme
unme
me
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0.50.5 1.0
1.0 1.0 1.0
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Figure 1 Examples of the assays used for the methylation analysis. The methylation of nine maternally methylated ICRs was analysed by MS-PCR
(a) and COBRA (b) in the DNAs of a normal individual and two BWS patients with multiple methylation defects (BWS1 and BWS2). The peaks of the
MS-PCR corresponding to unmethylated and methylated DNA are indicated by blue and red filled circles, respectively, and the bands of the COBRA
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Supplementary Tables 1 and 2. Note that the results obtained with the two techniques are highly concordant.
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methylation among nine maternally methylated and two
paternally methylated loci analysed, including a hypo-
methylation frequency of only 11% among the loci
investigated by Rossignol et al.9 This lower frequency
may reflect variations in the clinical inclusion criteria for
the two cohorts investigated; this is particularly significant
bearing in mind that multiple hypomethylation cases may
have a BWS presentation modified by the effects of loci
other than 11p15.5. Differently from Rossignol et al,9 we
used multiple techniques to analyse DNA methylation.
Notably, there was a broad concordance between the
results of methylation analysis by Southern blotting,
COBRA and MSP. In some cases, there was a variation
in the degree of hypomethylation detected by the
different techniques (for example, the hypomethylation
of KCNQ1OT1 in BWS1–4). In two cases (MEST, BWS16
and GNAS, BWS2), the discrepancy caused an apparently
divergent determination of hypomethylation, with MSP
detecting marginal hypomethylation not detected by
COBRA. In general, it appears that MSP is more sensitive
than COBRA to allelic imbalance. As MSP is based on
simultaneous amplification of methylated and non-methy-
lated DNAs with different primers, it is possible that the
different species take different times to reach exponential
phase, and this emphasises the differences between
methylated and non-methylated DNAs. Aside from this,
small discrepancies in calculated methylation ratios may
reflect the different positions of the target CpG dinucleo-
tides assayed by the different tests.
The loci most frequently affected in our patient cohort
were the NESPAS and GNAS ICRs on chromosome 20,
followed by the MEST, PLAGL1 and IGF2R ICRs, whereas
GRB10, PEG3 and SNRPN were frequently spared. This may
represent clinical ascertainment bias among the patient
cohort. Alternatively, the range of loci implicated may
indicate underlying mechanistic aetiologies primarily
affecting specific groups of imprinted loci. It has been
recently demonstrated that TND patients with gene
mutations in ZFP57 had imprinting defects chiefly affect-
ing the PLAGL1, PEG3 and GRB10 loci, whereas other loci
including KCNQ1OT1, MEST, NESPAS and GNAS were
generally spared.18 We suggest, therefore, that there may
be an aetiological divergence between that patient group
and the cohort described here.
Rossignol et al9 did not identify any significant difference
between the clinical features of patients with multiple
hypomethylation and those with hypomethylation restric-
ted to 11p15.5. In a more extensive characterisation,
we have found that patients with multiple defects were
on average smaller at birth than those with ICD2 alone.
In addition, some of the individuals with multiple
hypomethylation had unusual BWS phenotypes. Similarly
to a case of the French study, one patient of our cohort
(BWS3) had developmental delay and primary speech
retardation associated with MEST hypomethylation. An-
other patient with multiple methylation defect (BWS11)
showed apnoea and feeding and hearing problems. In
addition, two patients of our cohort (BWS12 and BWS16)
and one patient of the French cohort were born preterm.
Therefore, it is possible that dysregulation of additional
genes may modify the typical phenotype of BWS. The
tumour incidence (low in the BWS cases with ICD2),
however, was not affected by the presence of multiple
methylation defects.
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Figure 2 Multiple hypomethylated ICRs, as analysed by bisulphite sequencing. The methylation of the three maternally methylated ICRs was
analysed by bisulphite sequencing in the DNAs of a normal individual and two BWS patients with multiple methylation defects (BWS1 and BWS2).
Twenty-five CpGs of the KCNQ1OT1 ICR, 26 CpGs of the PLAGL1 ICR and 59 CpGs (only the first 25 CpGs are shown) of the MEST ICR were analysed.
Each line corresponds to a single template DNA molecule cloned; each circle corresponds to a CpG dinucleotide. Filled circles designate methylated
cytosines; open circles, unmethylated cytosines. Numbers at the right border of the CpG circles indicate multiple sequenced clones with identical
methylation pattern. Note that the hypomethylation extends over the entire amplicons sequenced.
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It is striking that some individuals manifested imprint-
ing defects that would be expected in association with
clinical features of another imprinting disorder. For
example, four patients (BWS8, BWS14, BWS15 and
BWS16) had total or near-total hypomethylation of GNAS
and/or NESPAS. The GNAS locus on chromosome 20q13 is
a complex imprinted cluster with multiple ICRs and
gene products.24 Hypomethylation at these ICRs has also
been described in several patients affected with PHP1b.25
Although further investigation is probably needed to
exclude all features of PHP1b, no alteration of calcium
metabolism has been reported in our BWS patients with
multiple hypomethylation so far. However, the two
patients with more marked GNAS hypomethylation were
not macrosomic at birth (10th and 50–90th centiles,
respectively), suggesting that abnormal expression at the
GNAS locus may modify the BWS phenotype. Four patients
(BWS1, BWS2, BWS9 and BWS10) in this cohort displayed
complete or near-complete hypomethylation of PLAGL1
ICR, which is normally associated with TND. Although
neonatal diabetes was not described among these cases,
they were not macrosomic; this suggests that PLAGL1
hypomethylation may alter the clinical presentation of
BWS. Interestingly, TND patients with marked KCNQ1OT1
hypomethylation displayed macroglossia and abdominal
wall defects, features typical of BWS.10 These observations
suggest that the clinical presentation of these complex
cases may be modified to an extent depending on their
mosaic epigenotype. Possibly, the lack of presentation
reflects the somatic mosaicism of the patients, with critical
target tissues being spared. Alternatively, the interaction of
genetic pathways affected by these different imprinted
genes gives rise to a primary clinical presentation, with
other clinical disorders being ameliorated. Also, it is not
possible to exclude that the observed loss of methylation at
ICRs other than KCNQ1OT1 is limited to blood leukocytes.
Clearly larger cohort studies, with extensive clinical and
epigenetic characterisations, are warranted.
Consistent with the French study, hypomethylation was
incomplete in most cases, indicating epigenetic mosaicism,
probably arising postfertilisation.9 It cannot be excluded,
however, that an imprinting defect originating in the
gametes results in unstable methylation of the ICRs
afterwards. The loss of methylation may arise stochastically
or as a consequence of defective trans-acting factor or
environmental cause. The use of assisted reproduction
technology (ART) can be excluded as a cause, as the
frequency of ART-associated cases is not increased among
the patients with multiple hypomethylation in both the
French9 and our studies (Table 2). Our results also exclude
defects in the DNMT3L gene as a common cause of
multiple hypomethylation in the BWS. The multi-zinc
finger ZFP-57 gene has been implicated in the aetiology of
multiple hypomethylation in TND.18 This protein, which
is enriched in undifferentiated ES cells, may be required for
the maintenance of DNA methylation at specific ICRs in
early embryogenesis. It is possible that a defect in a similar
regulatory protein is involved in multiple hypomethyl-
ation in BWS.
Functional interactions between imprinted genes con-
trolling embryo growth have been proposed on the basis of
similar expression patterns.13,26 In addition, the product of
the PLAGL1 gene has been shown to bind in vitro the
KCNQ1OT1 ICR and activate the expression of the non-
coding KCNQ1OT1 RNA.13 Also, extensive networks of
intra- and interchromosomal interactions were demon-
strated among imprinted domains.27 As a consequence of
these interactions, it is possible that epigenetic alterations
at one locus may result in abnormalities at other loci.
In conclusion, hypomethylation at multiple maternally
methylated imprinted loci, including KCNQ1OT1, MEST,
GNAS/NESPAS, PLAGL1 and IGF2R, is associated with
atypical BWS presentations. These cases may be an
example of a group of more generalised imprinting
disorders resulting from defects in the imprinting main-
tenance factors. Further investigation will be necessary
to identify the involved gene(s) and better define the
phenotypes associated with these complex disorders.
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